Trifiro', G., Mokhles, M., Dieleman, J., van Soest, E., Mazzaglia, G., Herings, R., et al. (2010). Risk of Cardiac Valve Regurgitation with Dopamine Agonist Use in Parkinson's Disease and Hyperprolactinemia. Intervento presentato a: 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Brighton, England.

Risk of Cardiac Valve Regurgitation with Dopamine Agonist Use in Parkinson's Disease and Hyperprolactinemia

Mazzaglia G;
2010

abstract
Dopamine Agonist, Parkinson's, real-world data, Cardiac Valve Regurgitation, case-control
English
26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
2010
2010
19
S275
S276
reserved
Trifiro', G., Mokhles, M., Dieleman, J., van Soest, E., Mazzaglia, G., Herings, R., et al. (2010). Risk of Cardiac Valve Regurgitation with Dopamine Agonist Use in Parkinson's Disease and Hyperprolactinemia. Intervento presentato a: 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Brighton, England.
File in questo prodotto:
File Dimensione Formato  
2010-Pharmacoepidemiology_and_Drug_Safety.pdf

Solo gestori archivio

Dimensione 2.81 MB
Formato Adobe PDF
2.81 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/285719
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact